Pharma positions itself for 2026 amid an evolving US landscape [Yahoo! Finance]
Certara, Inc. (CERT)
Company Research
Source: Yahoo! Finance
From tariffs and onshoring initiatives to Most Favored Nation (MFN) agreements, companies are adjusting their practices to strengthen their position in the lucrative US market. Given the scale of these developments, CEOs and executives are closely monitoring the news, says Kit Conklin, senior vice president of Risk & Compliance at Exiger, and an advisor involved in the creation of the BIOSECURE Act. “I don't have to educate executives about policy issues anymore. It's been an eye-opening year for CEOs and senior leaders at pharma companies and medical device companies.” Arguably, one of the biggest developments in the US space in 2025 has been MFN . The executive order, which aligns drug prices in the US with other developed countries, would see drugs put onto TrumpRx,gov, a government-led direct-to-consumer (DTC) platform. John Riddle, managing director of healthcare investment at Brown Gibbons Lang (BGL), an independent investment bank and financial advisory firm, believes
Show less
Read more
Impact Snapshot
Event Time:
CERT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERT alerts
High impacting Certara, Inc. news events
Weekly update
A roundup of the hottest topics
CERT
News
- Certara (NASDAQ:CERT) had its price target lowered by analysts at Morgan Stanley from $16.00 to $12.00. They now have an "equal weight" rating on the stock.MarketBeat
- Certara (NASDAQ:CERT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Certara (NASDAQ:CERT) had its price target lowered by analysts at Stephens from $15.00 to $12.00. They now have an "overweight" rating on the stock.MarketBeat
- Certara (CERT) Valuation Check as New CEO Jon Resnick Takes Over and Outlook Is Reaffirmed [Yahoo! Finance]Yahoo! Finance
- Certara Appoints Jon Resnick as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
CERT
Earnings
- 11/6/25 - Beat
CERT
Sec Filings
- 12/11/25 - Form 8-K
- 11/25/25 - Form SCHEDULE
- 11/12/25 - Form 4
- CERT's page on the SEC website